Monika Wielechowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Monika Wielechowska has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Maria Bretner
Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland
7 shared publications - Patrycja Wińska
Warsaw University of Technology, Faculty of Chemistry, Noakowskiego 3, 00-664 Warsaw, Poland
6 shared publications Jan Plenkiewicz
Warsaw University of Technology, Faculty of Chemistry, Noakowskiego St. 3, 00-664 Warsaw, Poland, Fax: +48-22-628-27-41, http://www.ch.pw.edu.pl/http://ztibsl.ch.pw.edu.pl
5 shared publications- Paweł Borowiecki
Laboratory of Biocatalysis and Biotransformation Department of Drug Technology and Biotechnology Faculty of Chemistry Warsaw University of Technology Warsaw Poland
5 shared publications - Edyta Łukowska-Chojnacka
Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland
3 shared publications - Konrad Chojnacki
Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland
3 shared publications
Latest Publications
- Open Access
- 20 July 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1991
Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1
CK2 and PIM-1 are serine/threonine kinases involved in the regulation of many essential processes, such as proliferation, differentiation, and apoptosis. Inhibition of CK2 and PIM-1 kinase activity has been shown to significantly reduce the viability of cancer cells by inducing apoptosis. A series of novel amino alcohol derivatives of parental DMAT were designed and synthesized as potent dual CK2/PIM-1 inhibitors. Concomitantly with the inhibition studies toward recombinant CK2 and PIM-1, the influence of the obtained compounds on the viability of three human carcinoma cell lines, i.e., acute lymphoblastic leukemia (CCRF-CEM), human chronic myelogenous leukemia (K-562), and breast cancer (MCF-7), as well as non-cancerous cells (Vero), was evaluated using an MTT assay. Induction of apoptosis and cell cycle progression after treatment with the most active compound and a lead compound were studied by flow-cytometry-based assay. Additionally, autophagy induction in K-562 cells and intracellular inhibition of CK2 and PIM-1 in all the tested cell lines were evaluated by qualitative/quantitative fluorescence-based assay and Western blot method, respectively. Among the newly developed inhibitors, 1,1,1-trifluoro-3-[(4,5,6,7-tetrabromo-1H-benzimidazol-2-yl)amino]propan-2-ol demonstrates the highest selectivity and the most prominent proapoptotic properties towards the studied cancer cells, especially towards acute lymphoblastic leukemia, in addition to inducing autophagy in K-562 cells.
- 20 July 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (7) , 1991
Open AccessSynthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1
CK2 and PIM-1 are serine/threonine kinases involved in the regulation of many essential processes, such as proliferation, differentiation, and apoptosis. Inhibition of CK2 and PIM-1 kinase activity has been shown to significantly reduce the viability of cancer cells by inducing apoptosis. A series of novel amino alcohol derivatives of parental DMAT were designed and synthesized as potent dual CK2/PIM-1 inhibitors. Concomitantly with the inhibition studies toward recombinant CK2 and PIM-1, the influence of the obtained compounds on the viability of three human carcinoma cell lines, i.e., acute lymphoblastic leukemia (CCRF-CEM), human chronic myelogenous leukemia (K-562), and breast cancer (MCF-7), as well as non-cancerous cells (Vero), was evaluated using an MTT assay. Induction of apoptosis and cell cycle progression after treatment with the most active compound and a lead compound were studied by flow-cytometry-based assay. Additionally, autophagy induction in K-562 cells and intracellular inhibition of CK2 and PIM-1 in all the tested cell lines were evaluated by qualitative/quantitative fluorescence-based assay and Western blot method, respectively. Among the newly developed inhibitors, 1,1,1-trifluoro-3-[(4,5,6,7-tetrabromo-1H-benzimidazol-2-yl)amino]propan-2-ol demonstrates the highest selectivity and the most prominent proapoptotic properties towards the studied cancer cells, especially towards acute lymphoblastic leukemia, in addition to inducing autophagy in K-562 cells.
- Open Access
- 10 June 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (12) , 6261
Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-1-ols—Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties
Protein kinase CK2 has been considered as an attractive drug target for anti-cancer therapy. The synthesis of N-hydroxypropyl TBBi and 2MeTBBi derivatives as well as their respective esters was carried out by using chemoenzymatic methods. Concomitantly with kinetic studies toward recombinant CK2, the influence of the obtained compounds on the viability of two human breast carcinoma cell lines (MCF-7 and MDA-MB-231) was evaluated using MTT assay. Additionally, an intracellular inhibition of CK2 as well as an induction of apoptosis in the examined cells after the treatment with the most active compounds were studied by Western blot analysis, phase-contrast microscopy and flow cytometry method. The results of the MTT test revealed potent cytotoxic activities for most of the newly synthesized compounds (EC50 4.90 to 32.77 µM), corresponding to their solubility in biological media. We concluded that derivatives with the methyl group decrease the viability of both cell lines more efficiently than their non-methylated analogs. Furthermore, inhibition of CK2 in breast cancer cells treated with the tested compounds at the concentrations equal to their EC50 values correlates well with their lipophilicity since derivatives with higher values of logP are more potent intracellular inhibitors of CK2 with better proapoptotic properties than their parental hydroxyl compounds.
- 10 June 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (12) , 6261
Open AccessSynthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-1-ols—Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties
Protein kinase CK2 has been considered as an attractive drug target for anti-cancer therapy. The synthesis of N-hydroxypropyl TBBi and 2MeTBBi derivatives as well as their respective esters was carried out by using chemoenzymatic methods. Concomitantly with kinetic studies toward recombinant CK2, the influence of the obtained compounds on the viability of two human breast carcinoma cell lines (MCF-7 and MDA-MB-231) was evaluated using MTT assay. Additionally, an intracellular inhibition of CK2 as well as an induction of apoptosis in the examined cells after the treatment with the most active compounds were studied by Western blot analysis, phase-contrast microscopy and flow cytometry method. The results of the MTT test revealed potent cytotoxic activities for most of the newly synthesized compounds (EC50 4.90 to 32.77 µM), corresponding to their solubility in biological media. We concluded that derivatives with the methyl group decrease the viability of both cell lines more efficiently than their non-methylated analogs. Furthermore, inhibition of CK2 in breast cancer cells treated with the tested compounds at the concentrations equal to their EC50 values correlates well with their lipophilicity since derivatives with higher values of logP are more potent intracellular inhibitors of CK2 with better proapoptotic properties than their parental hydroxyl compounds.
- 1 October 2018
- Published by Elsevier in Bioorganic Chemistry
- Vol. 80, 266-275
Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases
- 1 October 2018
- Published by Elsevier in Bioorganic Chemistry
- Vol. 80, 266-275
Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases
- 12 February 2018
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2018 (6) , 763-771
Synthesis of Carbohydrate Mimetics by Intramolecular 1,3‐Dipolar Cycloaddition of N‐(3‐Alkenyl)nitrones Derived from Unprotected d‐Aldopentoses
A concise synthesis of C‐furanosides has been achieved, starting from unprotected d‐xylose and d‐arabinose. Both sugars reacted with hydroxylamine 6 to give the respective nitrones. These underwent in‐situ intramolecular 1,3‐dipolar cycloaddition reactions to give, in each case, a pair of diastereomeric derivatives of 7‐oxa‐1‐aza‐bicyclo[2.2.1]heptane 7 and 8. The ratio of chromatographically separable diastereoisomers could be changed by carrying out the reaction in the presence of weak Lewis acid. Both d‐xylose‐derived stereoisomers 7a and 8a were converted into d‐erythro‐C‐furanosides by tosylation or mesylation followed by catalytic hydrogenolysis. On the other hand, the formation of d‐threo‐C‐furanosides from d‐arabinose derivatives 7b and 8b under similar conditions was accompanied by the formation of minor amounts of polyhydroxyquinolizidines as a result of competitive N‐alkylation. The polyhydroxyquinolizidine side‐products were useful for the assignment of the configuration of the new compounds.
- 12 February 2018
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2018 (6) , 763-771
Synthesis of Carbohydrate Mimetics by Intramolecular 1,3‐Dipolar Cycloaddition of N‐(3‐Alkenyl)nitrones Derived from Unprotected d‐Aldopentoses
A concise synthesis of C‐furanosides has been achieved, starting from unprotected d‐xylose and d‐arabinose. Both sugars reacted with hydroxylamine 6 to give the respective nitrones. These underwent in‐situ intramolecular 1,3‐dipolar cycloaddition reactions to give, in each case, a pair of diastereomeric derivatives of 7‐oxa‐1‐aza‐bicyclo[2.2.1]heptane 7 and 8. The ratio of chromatographically separable diastereoisomers could be changed by carrying out the reaction in the presence of weak Lewis acid. Both d‐xylose‐derived stereoisomers 7a and 8a were converted into d‐erythro‐C‐furanosides by tosylation or mesylation followed by catalytic hydrogenolysis. On the other hand, the formation of d‐threo‐C‐furanosides from d‐arabinose derivatives 7b and 8b under similar conditions was accompanied by the formation of minor amounts of polyhydroxyquinolizidines as a result of competitive N‐alkylation. The polyhydroxyquinolizidine side‐products were useful for the assignment of the configuration of the new compounds.
- 1 June 2017
- Published by Elsevier in Bioorganic Chemistry
- Vol. 72, 1-10
Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives
- 1 June 2017
- Published by Elsevier in Bioorganic Chemistry
- Vol. 72, 1-10
Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives
- 1 October 2016
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 100, 275-281
Production of natural 2-phenylethanol: From biotransformation to purified product
- 1 October 2016
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 100, 275-281
Production of natural 2-phenylethanol: From biotransformation to purified product
- 27 June 2016
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2016 (21) , 3642-3649
Diversity‐Oriented Synthesis and Biological Evaluation of Iminosugars from Unprotected 2‐Deoxy‐d‐ribose
- 27 June 2016
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2016 (21) , 3642-3649
Diversity‐Oriented Synthesis and Biological Evaluation of Iminosugars from Unprotected 2‐Deoxy‐d‐ribose
- Open Access
- 14 June 2016
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 147 (10) , 1789-1796
Synthesis of polybrominated benzimidazole and benzotriazole derivatives containing a tetrazole ring and their cytotoxic activity
A series of new benzimidazole and benzotriazole derivatives containing a tetrazole moiety was synthesized by N-alkylation of 5-aryltetrazole with 4,5,6,7-t
- 14 June 2016
- Published by Springer Nature in Monatshefte für Chemie - Chemical Monthly
- Vol. 147 (10) , 1789-1796
Open AccessSynthesis of polybrominated benzimidazole and benzotriazole derivatives containing a tetrazole ring and their cytotoxic activity
A series of new benzimidazole and benzotriazole derivatives containing a tetrazole moiety was synthesized by N-alkylation of 5-aryltetrazole with 4,5,6,7-t
- 1 February 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (4) , 735-741
Synthesis of novel polybrominated benzimidazole derivatives—potential CK2 inhibitors with anticancer and proapoptotic activity
- 1 February 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (4) , 735-741
Synthesis of novel polybrominated benzimidazole derivatives—potential CK2 inhibitors with anticancer and proapoptotic activity
- 1 January 2016
- Published by Elsevier in Tetrahedron Letters
- Vol. 57 (2) , 199-202
A new synthetic access to bicyclic iminosugars—derivatives of polyhydroxy decahydropyrido[1,2-a]azepine
- 1 January 2016
- Published by Elsevier in Tetrahedron Letters
- Vol. 57 (2) , 199-202
A new synthetic access to bicyclic iminosugars—derivatives of polyhydroxy decahydropyrido[1,2-a]azepine